Nanopharmaceutical Advanced Delivery Systems. Группа авторов
Читать онлайн книгу.
L., Zachariah, S.M., Pharmacogenomics: the right drug to the right person. J. Clin. Med. Res., 1, 4, 191–194, 2009.
22. Warrington, R., Silviu-Dan, F., Wong, T., Drug allergy. Allergy, Asthma Clin. Immunol., 14, 2, 60, 2018.
23. Arellano, A.L., Martin-Subero, M., Monerris, M., LLerena, A., Farré, M., Montané, E., Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result. Medicine (Baltimore), 96, 45, 8505, 2017.
24. Wilke, R.A., Lin, D.W., Roden, D.M., Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov., 6, 11, 904–916, 2007.
25. Gupta, P.D., Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: a paradigm shift. Indian J. Pharm. Sci., 77, 2, 135–141, 2015.
26. Pharmacogenetic and Pharmacodynamic Testing, Medical Clinical Policy Bulletins, Aetna, http://www.aetna.com/cpb/medical/data/700_799/0715.html, 2005.
27. Caudle, K.E., Gammal, R.S., Karnes, J.H. et al., PRN OPINION PAPER: Application of precision medicine across pharmacy specialty areas. J. Am. Coll. Clin. Pharm., 2, 288–302, 2019. https://doi.org/10.1002/jac5.1107.
28. Gonçalves, G.A.R. and Paiva, R.M.A., Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo, Brazil), 15, 3, 369–375, 2017.
29. Riley, M.K. and Vermerris, W., Recent Advances in Nanomaterials for Gene Delivery-A Review. Nanomaterials (Basel), 7, 5, 94, 2017.
30. Ventola, C.L., Progress in Nanomedicine: Approved and Investigational Nanodrugs. Pharm. Ther., 42, 12, 742–755, 2017.
31. Farris, E., Brown, D.M., Ramer-Tait, A.E., Pannier, A.K., Micro- and nanoparticulates for DNA vaccine delivery. Exp. Biol. Med. (Maywood), 241, 9, 919–929, 2016.
32. Khan, I. and Khalid, S., Nanoparticles: Properties, applications and toxicities. Arab. J. Chem., 12, 7, 908–931, 2019.
33. Mishra, V., Bansal, K.K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., Rosenholm, J.M., Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics, 10, 4, 191, 2018.
34. Ji, S-r., Liu, C., Zhang, B., Yang, F., Xu, J., Long, J., Jin, C., Fu, D.-l., Ni, Q.-x., Yu, X.-j., Carbon nanotubes in cancer diagnosis and therapy. Biochim. Biophys. Acta, 1806, 29–35, 2010.
35. Selvaraj, K., Kuppusamy, G., Krishnamurthy, J., Mahalingam, R., Singh, S.K., Gulati, M., Repositioning of Itraconazole for the Management of Ocular Neovascularization Through Surface-Modified Nanostructured Lipid Carriers. Assay Drug Dev. Technol., 17, 4, 178–90, 2019.
36. Bhatia, S., Nanopaticles types, classification, characterization, fabrication method and drug delivery applications, Natural polymer drug delivery systems, Springer International Publishing, Switzerland, 2016.
37. Croy, S.R. and Kwon, G.S., Polymeric Micelles for Drug Delivery. Curr. Pharm. Des., 12, 36, 4669–4684, 2006.
38. Abbasi, E., Aval, S.F., Akbarzadeh, A. et al., Dendrimers: synthesis, applications, and properties. Nanoscale Res. Lett., 9, 1, 247, 2014.
39. Venkatesh, N., Metallic Nanoparticle: A Review. Biomed. J. Sci. Tech. Res., 4, 2, 3765–75, 2018.
40. Kumari, Y., Kaur, G., Kumar, R., Singh, S.K., Gulati, M., Khursheed, R. et al., Gold nanoparticles: New routes across old boundaries. Adv. Colloid Interface Sci., 274, 102037, 2019.
41. Mody, V.V., Siwale, R., Singh, A., Mody, H.R., Introduction to metallic nanoparticles. J. Pharm. Bioallied Sci., 2, 4, 282–289, October-December 2010.
42. Reshma, V.G. and Mohanan, P.V., Quantum dots: Applications and safety consequences. J. Lumin., 205, 287–298, 2018.
43. Sharma, M., Sharma, R., Jain, D.K., Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water-Soluble Antihypertensive Drugs. Scientifica, 11, 8525679, 2016.
44. Patil, M., Mehta, D.S., Guvva, S., Future impact of nanotechnology on medicine and dentistry. J. Indian Soc. Periodontol., 12, 2, 34–40, 2008.
45. Raza, S., Blackburn, L., Moorthie, S., Cook, S., Johnson, E., Gaynor, L. et al., The Personalised Medicine Technology Landscape, p. 206, PHG Foundation, 2018.
46. Patra, J.K., Das, G., Fraceto, L.F. et al., Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol., 16, 1, 71, 2018.
47. Singh, R. and Lillard, J.W., Jr., Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 86, 3, 215–223, 2009.
48. Abeer, S., Future medicine: Nanomedicine. J. Int. Med. Sci. Acad., 25, 3, 187–92, 2012.
49. Fakruddin, M., Hossain, Z., Afroz, H., Prospects and applications of nanobiotechnology: a medical perspective. J. Nanobiotechnol., 10, 31, 2012.
50. Fornaguera, C. and García-Celma, M.J., Personalized Nanomedicine: A Revolution at the Nanoscale. J. Pers. Med., 7, 4, 12, 2017.
51. Soares, S., Sousa, J., Pais, A., Vitorino, C., Nanomedicine: Principles, Properties, and Regulatory Issues. Front. Chem., 6, 360, 2018.
52. Pelaz, B., Alexiou, C., Alvarez-Puebla, R.A. et al., Diverse Applications of Nanomedicine. ACS Nano, 11, 3, 2313–2381, 2017.
53. Shi, J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett., 10, 9, 3223–3230, 2010.
54. B.M., Nanosize drug delivery system. Curr. Pharm. Biotechnol., 14, 1221, 2013.
55. Begley, D.J., Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol. Ther., 104, 1, 29–45, 2004.
56. Razzak, R.A., Florence, G.J., Gunn-Moore, F.J., Approaches to CNS drug delivery with a focuson transporter-mediated transcytosis. Int. J. Mol. Sci., 20, 12, 3108, 2019.
57. Berkowitz, C., Mosconi, L., Scheyer, O., Rahman, A., Hristov, H., Isaacson, R., Precision Medicine for Alzheimer’s Disease Prevention. Healthcare, 6, 3, 82, 2018.
58. Solomon, A., Turunen, H., Ngandu, T., Peltonen, M., Levalahti, E., Helisalmi, S., Antikainen, R., Backman, L., Hanninen, T., Jula, A. et al., Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial. JAMA Neurol., 75, 462–470, 2018.
59. Sakhrani, N.M. and Padh, H., Organelle targeting: third level of drug targeting. Drug Des. Devel. Ther., 7, 585–599, 2013.
60. Krzyszczyk, P., Acevedo, A., Davidoff, E.J. et al., The growing role of precision and personalized medicine for cancer treatment. Technology (Singap. World Sci.), 6, 3-4, 79–100, 2018.
61. Food, U.S., FDA Science Forum, https://www.fda.gov/science-research/fda-science-forum/2015-fda-science-forum, 20152015.
62. Reuter, J.A., Spacek, D.V., Snyder, M.P., High-throughput sequencing technologies. Mol. Cell., 58, 4, 586–597, 2015.
63. Bezzon, V.D.N., Montanheiro, T.L.A., de Menezes, B.R.C. et al., Carbon Nanostructure-based Sensors: A Brief Review on Recent Advances. Adv. Mater. Sci. Eng., 2019, 1–21, 2019.
64. Mochalin, V., Shenderova, O., Ho, D. et al., The properties and applications of nanodiamonds. Nature Nanotechnol., 7, 11–23, 2012.
65. Karri, V.V.S.N.R., Current perspective in the management